VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into Crescent Biopharma, Inc. (CBIO) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $485M · revenue $11.9M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows